Ajay K Gopal, MD¹, Oliver W. Press, MD, PhD², Jonathan R Fromm, MD, PhD^3*, Shani Wilbur, BS^4* and John M. Pagel, MD, PhD⁵

¹University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Laboratory Medicine, University of Washington, Seattle
⁴Fred Hutchinson Cancer Research Center, Seattle
⁵Division of Oncology, Fred Hutchinson Cancer Research Ctr., Seattle, WA

Eugene A. Zhukovsky, PhD¹, Holly Horton, Ph.D^1*, Matthias Peipp, PhD^2*, Erik Pong, BS^1*, Matthew Bernett, PhD^1*, Sher Karki, PhD^1*, John Richards, PhD^1*, Seung Chu, PhD^1*, Roland Repp, MD² and John Desjarlais, PhD^1*

¹Xencor, Monrovia, CA
²Div. of Stem Cell Transp. and Immunoth., 2nd Medical Department, Christian-Albrechts-University; Kiel, Kiel, Germany

Michael Wang, MD¹, Luhong Sun, PhD^1*, Jianfei Qian, PhD¹, Xiaohong Han, PhD^1*, Liang Zhang, PhD^1*, Pei Lin, MD^2* and Qing Yi, MD, PhD^1*

¹Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX
²Department of Hematopathology, Division of Pathology and Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX

Tim Illidge, MD, PhD¹, Andrei Ivanov, PhD^1*, Stephen A Beers, PhD^2*, Claire Walshe, PhD^2*, Claude Chan, PhD^2*, Waleed Alduaij^1*, Martin J. Glennie, PhD^2* and Mark S Cragg^2*

¹Paterson Institute for Cancer Research, School of Cancer and Imaging Sciences, University of Manchester, Manchester, United Kingdom
²Tenovus Laboratory, Cancer Sciences Division, Southampton, United Kingdom

Sarah Brennan, BS^1*, Brooke Meade, BA^1*, Qiuju Wang, MA^1*, George Weiner, MD² and William Matsui, MD¹

¹Johns Hopkins University, Baltimore, MD
²University of Iowa, Holden Comprehensive Cancer Ctr., Iowa City, IA

Alan G. Ramsay, PhD, Andrew J. Clear, BSc^*, Rewa Fatah, BSc^* and John G. Gribben, MD, DSc^*

Centre. for Medical Oncology, Institute of Cancer, Barts & The London School of Medicine, London, United Kingdom

Lapo Alinari, MD¹, Erin Hertlein, PhD^1*, David M. Goldenberg, ScD, MD^2*, Rosa Lapalombella, PhD^1*, Fengting Yan, MD, PhD^1*, Xiaoli Zhang, PhD^3*, David M. Lucas, PhD¹, Natarajan Muthusamy, PhD^1*, John C. Byrd, MD^1* and Robert A. Baiocchi, MD, PhD^1*

¹Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²Immunomedics, Inc., Morris Plains, NJ
³Center for Biostatistics, The Ohio State University, Columbus, OH

Rekha Rao^1*, Warren Fiskus^1*, Yonghua Yang^1*, Rajeshree Joshi^1*, Pravina Fernandez^1*, Pearl Lee^1*, Anand Jillella^1*, Jianguo Tao^2*, Peter Atadja^3*, Eduardo Sotomayor^2* and Kapil N. Bhalla¹

¹MCG Cancer Center, Medical College of Georgia, Augusta, GA
²H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Novartis Institute for Biomedical Research, Cambridge, MA